Design of the coop- erative study on glycemic control and complications in diabe- tes mellitus type 2: Veterans Affairs Diabetes Trial. J Diabetes Complications. 2003;17:314 322. 129. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD; VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes [published correction appears in Management of Comorbidities in Chronic Heart Failure CLINICAL STATEMENTS AND GUIDELINES N Engl J Med. 2009;361:1028]. N Engl J Med. 2009;360:129 139. doi: 10.1056/NEJMoa0808431. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545 2559. 131. Calles-Escand n J, Lovato LC, Simons-Morton DG, Kendall DM, Pop-Busui R, Cohen RM, Bonds DE, Fonseca VA, Ismail-Beigi F, Banerji MA, Failor A, Hamilton B. Effect of intensive com- pared with standard glycemia treatment strategies on mortal- ity by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care. 2010;33:721 727. doi: 10.2337/dc09-1471. 132. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR; American Diabetes Association (ADA); European Association for the Study of Diabetes (EASD). Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) [published correc- tion appears in Diabetes Care. 2013;36:490]. Diabetes Care. 2012;35:1364 1379. doi: 10.2337/dc12-0413. 133. 